Clinical Trials Corner

por Powles, Thomas
Publicado 2017

Patient and Healthcare Professional Perspectives from ESMO 2022 on Bladder and Kidney Cancer: A Podcast

por Filicevas, Alex, Powles, Thomas
Publicado 2023

The management of low-stage non-seminomatous germ cell tumors

por Lim, Louise, Powles, Thomas
Publicado 2012

Advice Regarding Systemic Therapy in Patients with Urological Cancers During the COVID-19 Pandemic

por Gillessen, Silke, Powles, Thomas
Publicado 2020

Patient and Healthcare Professional Perspectives from ESMO 2021 on Bladder and Kidney Cancer: A Podcast

por Filicevas, Alex, Powles, Thomas B.
Publicado 2022

Targeted treatment of metastatic castration-resistant prostate cancer with sipuleucel-T immunotherapy

por Mulders, Peter F., De Santis, Maria, Powles, Thomas, Fizazi, Karim
Publicado 2015

Is High Dose Therapy Superior to Conventional Dose Therapy as Initial Treatment for Relapsed Germ Cell Tumors? The TIGER Trial

por Feldman, Darren R., Huddart, Robert, Hall, Emma, Beyer, Jörg, Powles, Thomas
Publicado 2011

Cytoreductive nephrectomy in the current treatment algorithm

por Kuusk, Teele, Szabados, Bernadett, Liu, Wing Kin, Powles, Thomas, Bex, Axel
Publicado 2019

Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma

por Motzer, Robert J., Escudier, Bernard, Powles, Thomas, Scheffold, Christian, Choueiri, Toni K.
Publicado 2018

Clinical Characteristics and Outcome for Four SARS-CoV-2-infected Cancer Patients Treated with Immune Checkpoint Inhibitors

por Szabados, Bernadett, Abu-Ghanem, Yasmin, Grant, Michael, Choy, Julia, Bex, Axel, Powles, Thomas
Publicado 2020

Bladder cancer, a unique model to understand cancer immunity and develop immunotherapy approaches

por Song, Dongkui, Powles, Thomas, Shi, Lei, Zhang, Lirong, Ingersoll, Molly A, Lu, Yong‐Jie
Publicado 2019

Role of Perioperative Immune Checkpoint Inhibitors in Muscle Invasive Bladder Cancer

por Chhaya, Saachi, Watts, Isabella, Ng, Kenrick, Mustapha, Rami, Powles, Thomas, Sharma, Anand, Vasdev, Nikhil
Publicado 2023

The efficacy and safety of irinotecan cisplatin and mitomycin chemotherapy in sunitinib pre-treated metastatic clear cell renal cancer

por Powles, Thomas, McFaul, Siobhan, Stebbing, Justin, Wilson, Peter, Oliver, Tim, Tranter, Naomi, Shamash, Jonathan
Publicado 2008

Perspectives on sipuleucel-T: Its role in the prostate cancer treatment paradigm

por Gulley, James L., Mulders, Peter, Albers, Peter, Banchereau, Jacques, Bolla, Michel, Pantel, Klaus, Powles, Thomas
Publicado 2015

Benchmarking Maintenance Therapy Survival in First-Line Platinum-Based Chemotherapy–Treated Patients with Advanced Urothelial Carcinoma Using Simulated Disease Modeling

por Galsky, Matthew D, Wirtz, Heidi S, Bloudek, Brian, Hepp, Zsolt, Farrar, Mallory, Timmons, Jack, Lenero, Enrique, Powles, Thomas
Publicado 2023

Axitinib plus immune checkpoint inhibitor: evidence- and expert-based consensus recommendation for treatment optimisation and management of related adverse events

por Grünwald, Viktor, Voss, Martin H., Rini, Brian I., Powles, Thomas, Albiges, Laurence, Giles, Rachel H., Jonasch, Eric
Publicado 2020

First Evidence of Activity of Enfortumab Vedotin on Brain Metastases in Urothelial Cancer Patients

por Vulsteke, Christof, De Cocker, Laurens, Gómez de Liaño, Alfonso, Montesdeoca, Cristina, De Meulenaere, Astrid, Croes, Lieselot, Delombaerde, Danielle, Szabados, Bernadett, Powles, Thomas
Publicado 2023

ATLANTIS: a randomised multi-arm phase II biomarker-directed umbrella screening trial of maintenance targeted therapy after chemotherapy in patients with advanced or metastatic uro...

por Fulton, Ben, Jones, Robert, Powles, Thomas, Crabb, Simon, Paul, James, Birtle, Alison, Chowdhury, Simon, Hussain, Syed, Morris, Anna, Soulis, Eileen, Morrison, Paula
Publicado 2020

Heterogeneous response and progression patterns reveal phenotypic heterogeneity of tyrosine kinase inhibitor response in metastatic renal cell carcinoma

por Crusz, Shanthini M., Tang, Yen Zhi, Sarker, Shah-Jalal, Prevoo, Warner, Kiyani, Irfan, Beltran, Luis, Peters, John, Sahdev, Anju, Bex, Axel, Powles, Thomas, Gerlinger, Marco
Publicado 2016

Avelumab first-line maintenance plus best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma: JAVELIN Bladder 100 Japanese subgroup analysis

por Tomita, Yoshihiko, Yamamoto, Yoshiaki, Tsuchiya, Norihiko, Kanayama, Hiroomi, Eto, Masatoshi, Miyake, Hideaki, Powles, Thomas, Yoshida, Mizuki, Koide, Yuichiro, Umeyama, Yoshiko, di Pietro, Alessandra, Uemura, Hirotsugu
Publicado 2022